Top of the page.
Skip the menu to main contents.
Move to main menu.
Skip to main contents.


Main menu starts here.
Skip the main menu to current location in your website.

Current location in your website.
Skip to main contents.


External Alliances and M&A

 

Acquisition of new business through external alliances and M&A

Since the start of the VISION75, our Medium-term Management Plan in 2004, we have been aggressively advancing capital investment, external alliances and M&A to shift our business structure. We invested about 250 billion yen in M&A from 2006 to March 2008. Active M&A is particularly being pursued to expand business in priority fields and to develop new businesses such as the life science business.
We conduct M&A after determining, under a given expected return criterion, whether Fujifilm's core technologies or businesses (including associated businesses) and the prospective acquisition would generate synergies for continued success. In this fashion, we decided to acquire Toyama Chemical from the medium-to-long term perspective once we had confirmed that this would offer a tremendous business opportunity based on application of the above principles.
The inkjet business is an example of our efforts to expand the fundamental capabilities of existing businesses. Here, we carried out key M&A in the industries of ink and printer heads, which form the core of marking technology. Our specific acquisitions from 2005 to 2006 included the top U.K. industrial ink manufacturer Sericol Group Limited (currently FUJIFILM Sericol UK Limited), the U.K. consumer inkjet printer ink company Avecia Inkjet Limited (currently FUJIFILM Imaging Colorants Limited) and the leading U.S. industrial inkjet printhead manufacturer Dimatix, Inc. (currently FUJIFILM Dimatix, Inc.).

R&D collaborations involving industry, government and academia

Fujifilm Group, taking into consideration future directions, pursues R&D in diverse fields. We therefore take up the challenges in innovative technological areas through a myriad of joint research efforts with universities and public research institutes. We vigorously encourage knowledge exchanges in cutting-edge fields to revitalize research and human resources. Specific initiatives involving major universities and research institutes for this purpose include participation in industry-government-academia collaborations, the opening of endowed courses and organizational collaborations, and collaborative ventures developed by those institutions. In addition, we actively address the researches for public benefits commissioned by the New Energy and Industrial Technology Development Organization (NEDO) and Japan Science and Technology Agency (JST). We are also advancing joint efforts with overseas research institutions, directly or indirectly through the laboratories of our overseas subsidiaries.

Representative collaborative efforts

Industry-government-academia collaboration

University of Tokyo, Tokyo Institute of Technology, National Institute of Advanced Industrial Science and Technology, Japan Chemical Innovation Institute

Endowed course

University of Tokyo


Organizational collaboration

Kyushu University, Tokyo University of Agriculture and Technology

Venture developed by universities / public research institutes

University of Tokyo, Institute of Physical and Chemical Research (RIKEN)


Related Information

Drug discovery company that leads Fujifilm Group's pharmaceutical products field.

The Fujifilm Group exercises sound management principles as a corporation that earns the public trust.


Footer starts here.

Pages ends here.
Move to top of the page.